APA (7th ed.) Citation

HM, G., S, G., S, B., G, M., RE, R., NS, K., . . . PW, S. (2012). Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). The international journal of cardiovascular imaging, 28(3), 455. https://doi.org/10.1007/s10554-011-9836-z

Chicago Style (17th ed.) Citation

HM, García-García, et al. "Evaluation of In-stent Restenosis in the APPROACH Trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in Diabetes Patients with Cardiovascular History)." The International Journal of Cardiovascular Imaging 28, no. 3 (2012): 455. https://doi.org/10.1007/s10554-011-9836-z.

MLA (9th ed.) Citation

HM, García-García, et al. "Evaluation of In-stent Restenosis in the APPROACH Trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in Diabetes Patients with Cardiovascular History)." The International Journal of Cardiovascular Imaging, vol. 28, no. 3, 2012, p. 455, https://doi.org/10.1007/s10554-011-9836-z.